doi: 10.1093/nar/gkae973 Summary Keywords atheroscelrosis, cholesterol metabolism, acetyl-L-carnitine (ALC), SREBP2, HMGCR Citation Xing J, Du Z, Li F, Wang Y, Zhang Z, Gao X, Han L, Sun X, Sun H, Du Y, Hu C, Yu H and Qin Y (2024) Acetyl-L-carnitine ameliorates atherosclerosis in LDLR / mice by modulating cholesterol metabolism through SREBP2-dependent cholesterol biosynthesis
Said et al., 1998
2 weeks in and down 6 lbs
A GLP-1 receptor agonist medication may help patients with psoriasis.[ref] Related article: T Cell Exhaustion Asthma symptoms decrease: Asthma exacerbations also decreased in patients on GLP-1 receptor agonist medications.[ref] ( Related article : Asthma genes) Dementia and Alzheimers Prevention: In animal studies, infusions of GLP-1 decrease amyloid-beta levels and prevent neuronal cell death.[ref] Dysregulation of glucose entry into the brain is one hallmark of Alzheimers disease, tying together insulin resistance, GLP-1, and dementia.[ref][ref] GLP-1 receptor agonist drugs, such as liraglutide, are being studied for Alzheimers disease.[ref] Studies using data from diabetes patients showed a significant decrease in dementia for those on GLP-1s vs other diabetes medications
